DS
ASPN icon

David Shaw’s Aspen Aerogels ASPN Stock Holding History

David Shaw’s Portfolio ASPN Stock Details ASPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-21,200
Closed -$1.06M – 5512
2021
Q4 		$1.06M Buy
+21,200
New +$1.12M ﹤0.01% 3886

Other funds holding ASPN

KL
KIM LLC Wichita, Kansas $1B AUM 29.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OCMI
Oaktop Capital Management II Chatham, New Jersey $2.35B AUM 214.39% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NIM
Needham Investment Management New York $3.33B AUM 163.16% 1-Year Est. Return
GKFF
George Kaiser Family Foundation Tulsa, Oklahoma $1.04B AUM 36.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

David Shaw's ASPN Position: Q2 2026 in Review

David Shaw increased its Aspen Aerogels (ASPN) stake by 28% in Q2 2026, buying an estimated $1.14M and bringing the position to 1,066,501 shares worth $6.76M. The position accounts for ﹤0.01% of the portfolio, ranked #2166.

David Shaw first reported a position in ASPN in Q2 2022 and has held it in 12 quarters since. The position peaked at $12.9M in Q2 2024. 180 funds tracked by Wall St. Rank hold ASPN as of Q2 2026.

  • David Shaw held 1,066,501 shares of Aspen Aerogels worth $6.76M as of Q2 2026.
  • David Shaw bought 232,929 Aspen Aerogels shares in Q2 2026, an estimated $1.14M.
  • Aspen Aerogels made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #2166 holding.
  • David Shaw first reported a position in Aspen Aerogels in Q2 2022 and has held it in 12 quarters since.
  • David Shaw's Aspen Aerogels position peaked at $12.9M in Q2 2024.
  • 180 funds tracked by Wall St. Rank held Aspen Aerogels as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.